Cooper Companies, Inc. (COO) stock
COONasdaqOphthalmic GoodsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 16/3040% below fair value
$60.75+0.03 (+0.05%)
Close on Nov 18, 2026Market cap $11.55BP/E 20.7Yield –
Cooper Companies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cooper Companies's operating income for the twelve months ending Jul 31, 2026 was $544.20M, down 26.5% year over year. For fiscal 2025 it was $682.90M, down 3.2% from the year before. Over ten years it grew 11.2% a year on average. The highest annual figure on record is $705.70M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $682.90M | -3.2% |
| FY2024 | Oct 31, 2024 | $705.70M | +32.4% |
| FY2023 | Oct 31, 2023 | $533.10M | +5.0% |
| FY2022 | Oct 31, 2022 | $507.60M | +0.4% |
| FY2021 | Oct 31, 2021 | $505.80M | +62.2% |
| FY2020 | Oct 31, 2020 | $311.80M | -43.0% |
| FY2019 | Oct 31, 2019 | $546.70M | +35.6% |
| FY2018 | Oct 31, 2018 | $403.10M | -6.1% |
| FY2017 | Oct 31, 2017 | $429.10M | +32.4% |
| FY2016 | Oct 31, 2016 | $324.10M | +36.9% |
| FY2015 | Oct 31, 2015 | $236.70M | -22.8% |
| FY2014 | Oct 31, 2014 | $306.49M | +0.2% |
| FY2013 | Oct 31, 2013 | $305.95M | +8.0% |
| FY2012 | Oct 31, 2012 | $283.40M | +24.5% |
| FY2011 | Oct 31, 2011 | $227.56M | +19.8% |
| FY2010 | Oct 31, 2010 | $189.91M | +26.7% |
| FY2009 | Oct 31, 2009 | $149.86M | +18.0% |
| FY2008 | Oct 31, 2008 | $126.96M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $222.00M | +26.4% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | -$31.00M | -116.8% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $212.80M | +16.9% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $140.40M | -29.2% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $175.70M | -8.7% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $184.80M | +14.3% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $182.00M | +18.9% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $198.40M | +46.2% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $192.50M | +27.0% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $161.70M | +67.9% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $153.10M | +2.4% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $135.70M | +31.1% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $151.60M | +7.8% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $96.30M | -27.4% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $149.50M | +14.3% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $103.50M | -19.5% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $140.60M | +39.8% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $132.70M | -7.3% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $130.80M | -1.9% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $128.50M | +28.4% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $100.60M | +39.7% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $143.20M | +400.7% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $133.40M | +20.1% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $100.10M | -31.7% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $72.00M | -49.4% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $28.60M | -80.5% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $111.10M | +0.2% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $146.60M | +19.5% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $142.20M | +23.0% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $146.90M | +96.7% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $110.90M | +22.9% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $122.70M | +13.1% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $115.60M | +2.5% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $74.70M | -36.2% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $90.20M | -0.6% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $108.50M | +46.2% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $112.80M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $117.10M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $90.70M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $74.20M | – |
See a number that looks wrong?